Bicentric clinical trial with in vitro experiments to assess the effect of Fibrinogen (FGTW) on Coagulation in Thrombocytopenia
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2016
Price : $35 *
At a glance
- Drugs Fibrinogen (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2015 Planned End Date changed from 1 Jun 2015 to 1 Aug 2015, according to to ClinicalTrials.gov record.